Vascular Geometry Drives Stroke Risk in Sickle Cell Disease
American Journal of Hematology · 2026
DOI: 10.1002/ajh.70184 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, 2026. Verfasst von Weiqiang Liu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Inria, Research Center Saclay Île-De-France, Palaiseau, France. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Stroke. Die Arbeit nennt 44 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Sickle cell disease (SCD) is the leading cause of stroke in children and young adults, primarily due to cerebral vasculopathy (CV) occurring within the first decade of life. The main risk factor for CV is elevated blood velocity in intracranial arteries, contributing to stenosis formation in very young children. This study addresses three key questions: (i) the relationship between hemoglobin levels and intracranial blood velocities in SCD patients, (ii) additional factors contributing to elevated velocity beyond anemia, and (iii) the presence of flow anomalies. To investigate these aspects, biological and transcranial Doppler data from pediatric and adult SCD patients were analyzed. An image‐based in silico modeling approach was also developed to simulate blood flow in the internal carotid, anterior cerebral, and middle cerebral arteries of SCD patients, of different age classes, and prior to any possible stenosis. Analysis revealed that while anemia is a recognized CV risk factor, it does not fully explain elevated velocities, as no significant correlation was found in children under five. In in silico simulations, young patients reached pathological arterial intracranial velocities at physiological flow rates, whereas adults remained below risk thresholds even at high flow rates. Pathological velocities were primarily observed in distal internal carotid arteries, where stenoses often develop. High flow rates, small arterial diameters, and pronounced curvatures led to extreme velocities and complex flow, likely causing endothelial damage and promoting CV progression. These findings enhance understanding of hemodynamic mechanisms underlying SCD‐related stroke risk, paving the way for improved predictive models and early interventions. Trial Registration: ClinicalTrials.gov identifier: NCT05199766.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inria, Research Center Saclay Île-De-France, Palaiseau, France.
- Emergency Department, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.
- IMRB, INSERM, EFS, UPEC DREAMS Team Bartolucci, Créteil, France.
- Department of Bioengineering, Stanford University, Stanford, California, USA.
- Arts et Métiers Institute of Technology, LCPI, Paris, France.
- Univ Paris Est Créteil, Hôpitaux Universitaires Henri Mondor, APHP, Sickle Cell and Red Cell Disorders Referral Center-UMGGR, Créteil, France.
ORCID-Profile: Christian Kassasseya, Morgane Garreau, Thomas d'Humières, Nour Bekeziz
Zitieren
APA
Liu, W., Kassasseya, C., Papamanolis, L., Nguyen-Peyre, K. A., Garreau, M., Eckert, S., De Luna, G., d'Humières, T., de Pierrefeu, V., Arnaud, C., Bekeziz, N., Metteil, M. P. G., Provost, C., Gerbeau, J. F., Verlhac, S., Bartolucci, P., & Vignon-Clementel, I. (2026). Vascular Geometry Drives Stroke Risk in Sickle Cell Disease. American Journal of Hematology. https://doi.org/10.1002/ajh.70184
Vancouver
Liu W, Kassasseya C, Papamanolis L, Nguyen-Peyre KA, Garreau M, Eckert S, et al. Vascular Geometry Drives Stroke Risk in Sickle Cell Disease. American Journal of Hematology. 2026. doi:10.1002/ajh.70184
BibTeX
@article{Liu2026,
author = {Liu, Weiqiang and Kassasseya, Christian and Papamanolis, Lazaros and Nguyen-Peyre, Kim-Anh and Garreau, Morgane and Eckert, Saskia and De Luna, Gonzalo and d'Humières, Thomas and de Pierrefeu, Vincent and Arnaud, Cecile and Bekeziz, Nour and Metteil, Marie Pierre Gobin and Provost, Corentin and Gerbeau, Jean-Frédéric and Verlhac, Suzanne and Bartolucci, Pablo and Vignon-Clementel, Irene},
title = {Vascular Geometry Drives Stroke Risk in Sickle Cell Disease},
journal = {American Journal of Hematology},
year = {2026},
doi = {10.1002/ajh.70184}
}
EUVIMED